JP2013500959A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013500959A5 JP2013500959A5 JP2012522296A JP2012522296A JP2013500959A5 JP 2013500959 A5 JP2013500959 A5 JP 2013500959A5 JP 2012522296 A JP2012522296 A JP 2012522296A JP 2012522296 A JP2012522296 A JP 2012522296A JP 2013500959 A5 JP2013500959 A5 JP 2013500959A5
- Authority
- JP
- Japan
- Prior art keywords
- perfluoro
- contrast agent
- butylcyclohexane
- imaging
- butyl cyclohexane
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09166955.6 | 2009-07-31 | ||
| EP09166955 | 2009-07-31 | ||
| PCT/IB2010/053321 WO2011013038A2 (en) | 2009-07-31 | 2010-07-21 | Perfluoro compounds for use in imaging |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015221770A Division JP2016029098A (ja) | 2009-07-31 | 2015-11-12 | イメージングに用いるパーフルオロ化合物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013500959A JP2013500959A (ja) | 2013-01-10 |
| JP2013500959A5 true JP2013500959A5 (enExample) | 2014-12-18 |
| JP5840609B2 JP5840609B2 (ja) | 2016-01-06 |
Family
ID=43304070
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012522296A Expired - Fee Related JP5840609B2 (ja) | 2009-07-31 | 2010-07-21 | イメージングに用いるパーフルオロ化合物 |
| JP2015221770A Pending JP2016029098A (ja) | 2009-07-31 | 2015-11-12 | イメージングに用いるパーフルオロ化合物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015221770A Pending JP2016029098A (ja) | 2009-07-31 | 2015-11-12 | イメージングに用いるパーフルオロ化合物 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20120128589A1 (enExample) |
| EP (1) | EP2459235B1 (enExample) |
| JP (2) | JP5840609B2 (enExample) |
| CN (1) | CN102497888B (enExample) |
| WO (1) | WO2011013038A2 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101906574B1 (ko) * | 2013-01-15 | 2018-10-10 | 주식회사 엘지생활건강 | 발수성을 가지는 칫솔모 및 이를 포함하는 칫솔 |
| CN118859065A (zh) * | 2024-07-01 | 2024-10-29 | 中国科学院精密测量科学与技术创新研究院 | 一种利用凝血级联放大提升19f mri肿瘤信噪比的方法 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4453028A (en) * | 1982-03-29 | 1984-06-05 | Lagow Richard J | Perfluorinated compounds with cyclohexyl groups |
| US5236694A (en) | 1990-02-21 | 1993-08-17 | The Board Of Regents, The University Of Texas System | 19f labelled dextrans and antibodies as nmr imaging and spectroscopy agents |
| US5571498A (en) | 1994-06-02 | 1996-11-05 | Hemagen/Pfc | Emulsions of paramagnetic contrast agents for magnetic resonance imaging (MRI). |
| US6167887B1 (en) * | 1997-11-21 | 2001-01-02 | Synthetic Blood International, Inc. | Selected C-10 perfluorinated hydrocarbons for liquid ventilation and artificial blood |
| US7220401B2 (en) * | 1999-09-24 | 2007-05-22 | Barnes-Jewish Hospital | Blood clot-targeted nanoparticles |
| US6676963B1 (en) * | 2000-10-27 | 2004-01-13 | Barnes-Jewish Hospital | Ligand-targeted emulsions carrying bioactive agents |
| US6574497B1 (en) * | 2000-12-22 | 2003-06-03 | Advanced Cardiovascular Systems, Inc. | MRI medical device markers utilizing fluorine-19 |
| US6869591B2 (en) * | 2002-03-26 | 2005-03-22 | Barnes-Jewish Hospital | Paramagnetic particles that provide improved relaxivity |
| US8777889B2 (en) * | 2004-06-15 | 2014-07-15 | Ceramatec, Inc. | Apparatus and method for administering a therapeutic agent into tissue |
| EP1817098A1 (en) | 2004-10-29 | 2007-08-15 | Koninklijke Philips Electronics N.V. | Method and apparatus for the preparation of dispersions of particles for use as contrast agents in ultrasound imaging |
| WO2007127958A2 (en) * | 2006-04-27 | 2007-11-08 | Barnes-Jewish Hospital | Detection and imaging of target tissue |
| JP5366824B2 (ja) * | 2006-12-19 | 2013-12-11 | コーニンクレッカ フィリップス エヌ ヴェ | ２次元ビデオの３次元ビデオへの変換方法及びシステム |
| EP2130058B1 (en) | 2007-03-19 | 2013-05-15 | Koninklijke Philips Electronics N.V. | Fast magnetic resonance spectroscopic imaging |
| EP1985312A1 (en) | 2007-04-25 | 2008-10-29 | Koninklijke Philips Electronics N.V. | T1 reduction in 19F magnetic resonance imaging (MRI) |
| KR101005561B1 (ko) * | 2008-06-21 | 2011-01-05 | 한국생명공학연구원 | 광학특성 나노입자 및 퍼플루오로카본으로 구성된 나노에멀젼을 이용한 다중모드 조영 방법 |
| CN102395548A (zh) * | 2009-04-15 | 2012-03-28 | 奥斯金生医公司 | 全氟化碳类乳液 |
-
2010
- 2010-07-21 JP JP2012522296A patent/JP5840609B2/ja not_active Expired - Fee Related
- 2010-07-21 WO PCT/IB2010/053321 patent/WO2011013038A2/en not_active Ceased
- 2010-07-21 EP EP10740399.0A patent/EP2459235B1/en not_active Not-in-force
- 2010-07-21 US US13/387,748 patent/US20120128589A1/en not_active Abandoned
- 2010-07-21 CN CN201080041769.8A patent/CN102497888B/zh not_active Expired - Fee Related
-
2015
- 2015-11-12 JP JP2015221770A patent/JP2016029098A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Bort et al. | EPR-mediated tumor targeting using ultrasmall-hybrid nanoparticles: From animal to human with theranostic AGuIX nanoparticles | |
| Hsu et al. | Nanomaterial-based contrast agents | |
| Arms et al. | Advantages and limitations of current techniques for analyzing the biodistribution of nanoparticles | |
| Serkova et al. | Preclinical applications of multi-platform imaging in animal models of cancer | |
| Park et al. | Towards clinically translatable in vivo nanodiagnostics | |
| Ehlerding et al. | Big potential from small agents: nanoparticles for imaging-based companion diagnostics | |
| Li et al. | Multimodality imaging in nanomedicine and nanotheranostics | |
| Kim et al. | Recent development of nanoparticles for molecular imaging | |
| Lanza et al. | 1H/19F magnetic resonance molecular imaging with perfluorocarbon nanoparticles | |
| Mirabello et al. | Metallic nanoparticles as synthetic building blocks for cancer diagnostics: from materials design to molecular imaging applications | |
| Tuguntaev et al. | Bioimaging guided pharmaceutical evaluations of nanomedicines for clinical translations | |
| Xue et al. | Design of ProCAs (Protein‐Based Gd3+ MRI Contrast Agents) with High Dose Efficiency and Capability for Molecular Imaging of Cancer Biomarkers | |
| Misri et al. | Nanoprobes for hybrid SPECT/MR molecular imaging | |
| Wu et al. | Nanoparticle‐based imaging of inflammatory bowel disease | |
| Gonawala et al. | Application of dendrimer-based nanoparticles in glioma imaging | |
| Calle et al. | Advanced contrast agents for multimodal biomedical imaging based on nanotechnology | |
| Shaghaghi et al. | Multimodal imaging in cancer detection: the role of SPIONs and USPIONs as contrast agents for MRI, SPECT, and PET | |
| Liu et al. | Nanoprobes for PET/MR imaging | |
| Munley et al. | An introduction to molecular imaging in radiation oncology: A report by the AAPM Working Group on Molecular Imaging in Radiation Oncology (WGMIR) | |
| JP5840609B2 (ja) | イメージングに用いるパーフルオロ化合物 | |
| Wang et al. | Exponential growth of publications on carbon nanodots by Chinese authors | |
| Chandra et al. | Role of contrast in MR imaging | |
| Liu et al. | Translational nanodiagnostics for in vivo cancer detection | |
| Kang | Preliminary pre-clinical results and overview on PET/MRI/fluorescent molecular imaging | |
| Geraldes | Imaging Applications of Inorganic Nanomaterials |